Everolimus versus alpelisib in advanced hormone...

Breast Cancer Research 2020 / 12 Vol. 22; Iss. 1

Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications

Vernieri, Claudio, Corti, Francesca, Nichetti, Federico, Ligorio, Francesca, Manglaviti, Sara, Zattarin, Emma, Rea, Carmen G., Capri, Giuseppe, Bianchi, Giulia V., de Braud, Filippo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-020-01271-0
Date:
December, 2020
File:
PDF, 595 KB
2020
Conversion to is in progress
Conversion to is failed